| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.69B | 26.92B | 23.74B | 21.36B | 17.09B | 10.96B |
| Gross Profit | 27.69B | 26.92B | 23.74B | 21.36B | 17.09B | 10.96B |
| EBITDA | 9.51B | 9.22B | 9.34B | 7.04B | 4.92B | 2.40B |
| Net Income | 6.15B | 5.40B | 5.88B | 4.29B | 3.06B | 1.17B |
Balance Sheet | ||||||
| Total Assets | 27.72B | 29.26B | 27.71B | 24.34B | 25.36B | 23.64B |
| Cash, Cash Equivalents and Short-Term Investments | 16.02B | 17.79B | 16.16B | 12.68B | 12.43B | 11.15B |
| Total Debt | 18.94B | 19.29B | 17.08B | 14.78B | 13.04B | 11.28B |
| Total Liabilities | 36.44B | 34.84B | 31.73B | 27.09B | 22.58B | 17.46B |
| Stockholders Equity | -8.72B | -5.58B | -4.02B | -2.74B | 2.78B | 6.18B |
Cash Flow | ||||||
| Free Cash Flow | 9.03B | 9.09B | 7.89B | 7.00B | 6.19B | 2.52B |
| Operating Cash Flow | 9.34B | 9.41B | 8.32B | 7.34B | 6.55B | 2.82B |
| Investing Cash Flow | -302.00M | -313.00M | 129.00M | 1.49B | -518.00M | -998.00M |
| Financing Cash Flow | -8.97B | -8.91B | -4.20B | -8.91B | -4.90B | -1.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $81.06B | 31.67 | 31.24% | ― | 13.18% | 2.35% | |
67 Neutral | $27.31B | 18.49 | 147.58% | 0.56% | 10.01% | 33.63% | |
66 Neutral | $30.64B | 6.69 | 21.02% | 0.39% | 17.27% | 94.65% | |
62 Neutral | $131.59B | 21.49 | -95.80% | 0.71% | 14.95% | 17.45% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | $4.49B | 87.62 | -38.21% | ― | 6.71% | -41.74% | |
52 Neutral | $1.19B | 67.63 | 2.86% | ― | 2.03% | -64.68% |